The methylenetetrahydrofolate reductase (MTHFR) gene in colorectal cancer: Role in tumor development and significance of allelic loss in tumor progression

International Journal of Gastrointestinal Cancer

Volumn 30, Issue 3, 2001, Pages 105-111

  Ryan, Barbara M ^a,c   Molloy, Anne M ^b   McManus, Ross ^a   Arfin, Qamrul ^a   Kelleher, Dermot ^a   Scott, John M ^b   Weir, Donald G ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Genetics; LOH; MTHFR; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GENOMIC DNA;

ARTICLE; CASE CONTROL STUDY; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY;

EID: 0035785560     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:30:3:105     Document Type: Article

References (35)

1. Giovannucci E, Rimm E, Ascherio A, Stampfer M, Colditz G, Willett W. Alcohol, low-methionine low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995;87:265-273.
2. Giovannucci E, Stampfer M, Colditz G, et al. Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993;6685:875-884.
3. Ferraroni M, LaVecchio C, D'Avanzo B, Negri E, Franceschi S, Decarli A. Selected micronutrient intake and the risk of colorectal cancer. Br J Cancer 1994;70:1150-1155.
4. Baron J, Sandler R, Haile R, Mandel J, Mott L, Greenberg E. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst 1998;90:57-62.
5. Giovannucci E, Stampfer M, Colditz G, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Int Med 1998;129:517-524.
6. Gyde S, Prior P, Allan R, et al. Colorectal cancer in ulcerative colitis - a cohort study of primary referrals from three centres. Gut 1988;29:206-217.
7. Ekbom A, Helmick C, Zack M, Adami H. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 1990;323:1228-1233.
8. Lashner B, Heidenreich P, Su G, Kano S, Hanauer S. The effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 1989;97:255-259.
9. Kim I, Pogribny I, Basnakin A, et al. Folate deficiency in rats induces DNA strand breaks and hypomethylation within p53 tumor suppressor gene. Am J Clin Nutr 1997;65:46-52.
10. Fearon E, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
11. Pogribny I, Muskhelishvili L, Miller B, James S. Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. Carcinogenesis 1997;18:2071-2076.
12. James S, Miller B, Basnakian A, Pogribny I, Pogribna M, Muskhelishvili L. Apoptosis and proliferation under conditions of deoxynucleotide pool imbalance in liver of folate/methyl deficient rats. Carcinogenesis 1997;18:287-293.
13. Blount B, Mack M, Wehr C, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci 1997;94:3290-3295.
14. Frosst P, Blom H, Milos R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
15. Ma J, Stampfer M, Selhub J, et al. Methylenetetrahydrofolate reductase polymorphisms, plasma folate, homocysteine and risk of myocardial infarction in US physicians. Circulation 1996;94:2410-2416.
16. Molloy A, Daly S, Mills J, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997;349((9065)):1591-1593.
17. Stern L, Mason J, Selhub J, Choi S. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals whho are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000;9:849-853.
18. van der Put N, Steegers-Theunissen R, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1071.
19. Kang S, Wong P, Malinow M. Hyperhomocysteinaemia as a risk factor for occlusive vascular disease. Ann Rev Nutr 1992;12:279-98.
20. Adams M, Smith P, Martin D, Thompson J, Lodwick D, Samana N. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Quart J Med 1996;89:437-444.
21. Ulrich C, Kampmann E, Bigler J, et al. Colorectal Adenomas and the C677T MTHFR Polymorphism: Evidence for gene-Environment Interaction. Cancer, Epidemiol, Biomark, Prev 1999;8:659-668.
22. Marugame T, Tsuji E, Inoue H, et al. Methylenetetrahydrofolate reductase polymorphism and the risk of colorectal adenomas. Cancer Lett 2000;151:181-186.
23. Chen J, Giovannucci E, Hankinson S, et al. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 1998;19(12):2129-32.
24. Slattery M, Potter J, Samomitz W, Shaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1999;8 (6):513-518.
25. Chen J, Giovannucci E, Kelsey K, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996;56(21):4862-4.
26. Ma J, Stampfer M, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997;57(6):1098-1102.
27. Esteller M, Garcia A, Matrinez-Palones J, Xercavins J, Raventos J. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetatrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 1997;18(12):2307-2311.
28. Di Vinci A, Infusini E, Peveri C, Risio M, Rossini FP, Giaretti W. Deletions at chromosome 1p by fluorescence in situ hybridisation are an early event in human colorectal tumorigenesis. Gastroenterology 1996;111:102-107.
29. Viel A, Dall'Agnese L, Simone F, et al. Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer 1997;75(8):1105-1110.
30. Pereira P, Stanton V, Jothy S, Tomlinson I, Foulkes W, Rozen R. Loss of heterozygosity of methylenetetrahydrofolate reductase in colon carcinomas. Oncol Rep 1999;6(3):597-599.
31. Mills J, Kirke P, Molloy A, et al. Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet 1999;86:71-74.
32. Impraim C, Saiki R, Erlich H, Teplitz R. Analysis of DNA extracted from formalin-fixed, paraffin-embedded tissues by enzymatic amplification and hybridisation with sequence-specific oligonucleotides. Biochem Bio Res Comm 1987;142:710-716.
33. Raymond M, Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Heredity 1995;86:248-249.
34. Djurhuus D, Svardal A, Mansoor M, Usland P. Modulation of glutathione content and the effect on methionine auxotrophy and cellular distribution of homocysteine and cysteine in mouse cell lines. Carcinogenesis 1991;12:241-247.
35. van der Put N, Gabreels F, Stevens E, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk for neural tube defects. Am J Hum Genet 1998;62:1044-1051.